E-pill will know if you took it
The first drug with a sensor that can track whether patients have taken their medicine has been approved by US regulators.
The Abilify pill was first approved by the Food and Drug Administration in 2002 for schizophrenia, and the sensor technology was approved for marketing in 2012. The FDA said in a statement Monday that the system “works by sending a message from the pill’s sensor to a wearable patch.”
“Being able to track ingestion of medications prescribed for illness may be useful for some patients,” Dr. Mitchell Mathis of the FDA said in statement.
Abilify MyCite was developed by Otsuka Pharmaceutical Co. and the sensor was created by Proteus Digital Health. It lets patients track their dosage on their smartphone and their doctors or caregivers access the information online.
The FDA said digital Abilify is approved for the treatment of schizophrenia, bipolar disorder and as an add-on treatment for depression in adults.